Diagnostic options · UAE

NGS Genetic tests in Dubai & UAE

Compare available NGS Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

NGS Genetic test prices

Showing 1–9 of 9 matching tests.

NGS Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5435 DOCK6 Gene Adams‑Oliver Syndrome Type 2 Genetic Test This test analyzes the entire coding region and splice junctions of the DOCK6 gene to detect pathogenic variants associated with Adams‑Oliver syndrome type 2.	Peripheral whole blood (venous draw) or FTA card dried blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DOCK6 gene", "Coding region and splice junctions of DOCK6"] Parameters [] Preparation ["No fasting required", "No special preparation needed beyond providing complete clinical history and prior genetic test results"] Indications ["Suspected diagnosis of Adams‑Oliver syndrome type 2", "Family history of Adams‑Oliver syndrome type 2", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 90262-4 ICD-10: Q87.2 Clinical summary This test analyzes the entire coding region and splice junctions of the DOCK6 gene to detect pathogenic variants associated with Adams‑Oliver syndrome type 2.
TEST-5060 GORAB Gene Geroderma Osteodysplasticum Genetic Test This test evaluates the GORAB gene for pathogenic variants associated with Geroderma osteodysplasticum.	Peripheral whole blood or FTA card (finger prick)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GORAB gene sequence", "Pathogenic single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy-number changes"] Parameters [] Preparation [] Indications ["Individuals with clinical features suggestive of Geroderma osteodysplasticum", "Family history of Geroderma osteodysplasticum", "Consanguinity in parents of affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q78.8 Clinical summary This test evaluates the GORAB gene for pathogenic variants associated with Geroderma osteodysplasticum.
TEST-4857 ITGA3 Gene Genetic Test for Interstitial Lung Disease, Nephrotic Syndrome, and Epidermolysis Bullosa Congenita This diagnostic test evaluates the ITGA3 gene for pathogenic variants associated with interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa congenita.	Whole blood (EDTA), extracted DNA, Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ITGA3 gene sequence", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Diagnosis of suspected ITGA3-related disorder", "Family screening for ITGA3 variants"] Measurement technique Confirm with laboratory Codes LOINC: 88537-7 ICD-10: Q81.9 Clinical summary This diagnostic test evaluates the ITGA3 gene for pathogenic variants associated with interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa congenita.
TEST-2272 LIFR Gene Stuve‑Wiedemann Syndrome Genetic Test This genetic test identifies mutations in the LIFR gene associated with Stuve‑Wiedemann syndrome.	Peripheral whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LIFR gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Clinical history and pedigree chart required", "Pre-test genetic counselling session mandatory"] Indications ["Suspected Stuve‑Wiedemann syndrome", "Family history of Stuve‑Wiedemann syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 82373-9 ICD-10: Q87.8 Clinical summary This genetic test identifies mutations in the LIFR gene associated with Stuve‑Wiedemann syndrome.
TEST-5242 MSTN Gene Muscle Hypertrophy Genetic Test This genetic test evaluates the MSTN gene for pathogenic variants linked to muscle hypertrophy and related neuromuscular conditions.	Whole blood, extracted DNA, or one-drop blood on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MSTN gene", "Single-nucleotide variants", "Small insertions/deletions", "Splice-site alterations"] Parameters [] Preparation [] Indications ["Individuals with unexplained muscle hypertrophy", "Family history of myostatin-related disorders", "Athletes seeking molecular insights into muscle growth potential"] Measurement technique Confirm with laboratory Codes LOINC: 101103-7 ICD-10: M62.89 Clinical summary This genetic test evaluates the MSTN gene for pathogenic variants linked to muscle hypertrophy and related neuromuscular conditions.
TEST-5908 NADK2 Gene 2,4-Dienoyl-CoA Reductase Deficiency Genetic Test This genetic test evaluates the NADK2 gene for pathogenic variants associated with 2,4-dienoyl-CoA reductase deficiency.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NADK2 gene", "Point mutations", "Small insertions and deletions", "Copy number variants"] Parameters [] Preparation ["No fasting or special preparation needed"] Indications ["Confirming diagnosis of 2,4-dienoyl-CoA reductase deficiency", "Carrier screening", "Guiding dietary management"] Measurement technique Confirm with laboratory Codes LOINC: 101074-7 ICD-10: E71.3, Z13.71, Z14.8 Clinical summary This genetic test evaluates the NADK2 gene for pathogenic variants associated with 2,4-dienoyl-CoA reductase deficiency.
TEST-4191 PRRT2 Gene (DYT10) Genetic Test This test evaluates the PRRT2 gene for pathogenic variants associated with paroxysmal kinesigenic dyskinesia and related neurological disorders.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	21–28 days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRRT2 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation [] Indications ["Clinical suspicion of paroxysmal kinesigenic dyskinesia (PKD)", "Family history of PKD or related movement disorders", "Confirmed family history of a PRRT2 pathogenic variant"] Measurement technique Confirm with laboratory Codes LOINC: 81304-8 ICD-10: G24.8, G25.8 Clinical summary This test evaluates the PRRT2 gene for pathogenic variants associated with paroxysmal kinesigenic dyskinesia and related neurological disorders.
TEST-2868 SALL4 Gene Duane Retraction Syndrome Genetic Test This test identifies pathogenic variants in the SALL4 gene associated with Duane retraction syndrome and Okihiro syndrome.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SALL4 gene pathogenic variants", "Copy Number Variations (CNV) in SALL4 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Clinical suspicion of Duane retraction syndrome", "Clinical suspicion of Okihiro syndrome", "Familial recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 83202-2 ICD-10: H50.81 Clinical summary This test identifies pathogenic variants in the SALL4 gene associated with Duane retraction syndrome and Okihiro syndrome.
TEST-6174 UCP2 Gene Hyperinsulinism (UCP2-Related) Genetic Test This genetic test identifies mutations within the UCP2 gene associated with congenital hyperinsulinism.	Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UCP2 gene mutations", "Congenital hyperinsulinism genetic variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of congenital hyperinsulinism", "Identification of UCP2 gene mutations", "Genetic counseling for families with hyperinsulinism"] Measurement technique Confirm with laboratory Codes LOINC: 82386-1 ICD-10: P70.1 Clinical summary This genetic test identifies mutations within the UCP2 gene associated with congenital hyperinsulinism.

Category overview

NGS Genetic: overview

Understanding your underlying genetic predispositions empowers you and your family to make proactive, highly informed decisions for your long-term wellness. Representing a critical offering within our Molecular Genetics department, precise NGS Genetic testing evaluates your DNA to pinpoint inherited disease risks and intricate chromosomal variations. By leveraging state-of-the-art diagnostic technology, this advanced genetic profiling helps uncover subtle molecular changes, safely guiding highly personalized preventative care and medical oversight. Trusted by families and physicians across premier diagnostic labs in Dubai and the UAE, DNA Labs is steadfastly committed to strict patient confidentiality, unparalleled diagnostic accuracy, and highly efficient reporting. Protect your family’s future health—book your NGS genetic testing in UAE, arrange a seamless home sample collection, or reach out to our expert genetic counselors.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.